Delayed onset muscle sorenss. Soft tissue disorder, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: healthy subjects Exclusion criteria: positive history of cardiac disease, peripheral vascular disease, diabetes, epilepsy, neuromuscular disease, asthma, renal failure, total hip arthroplasty, total knee arthroplasty, acute hernia, discopathy, tumor, cardiac pacemaker, high blood pressure, migraine, participation in strength training program, having injection in a week before intervention, recently implanted pin and plaque
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum creatine kinase enzyme. Timepoint: before intervention, on 1, 2, and 7 days post intervention. Method of measurement: blood sample. | — |
Secondary
| Measure | Time frame |
|---|---|
| Isometric strength of quadriceps muscle. Timepoint: before intervention, on the days 1, 2, 7, and 14 postexercise. Method of measurement: isokinetic dynamometery, Biodex system 3.;Pressure pain threshold. Timepoint: before intervention, on the days 1, 2, 3, 4, 7, and 14 postexercise. Method of measurement: using a specific device instrumented for measuring pressure pain threshold.;Thigh circumferences. Timepoint: before intervention, on the days 1, 2, 3, 4, 7, and 14 postexercise. Method of measurement: tape measure.;Subjective pain (soreness). Timepoint: before intervention, on the days 1, 2, 3, 4, 7, and 14 postexercise. Method of measurement: Visual Analogue Scale.;Eccentric strength of quadriceps muscle. Timepoint: before intervention, on the days 1, 2, 7, and 14 postexercise. Method of measurement: isokinetic dynamometery, Biodex system 3. | — |
Countries
Iran (Islamic Republic of)
Contacts
Rehabilitation Faculty